Evaxion A (EVAX) Other Accumulated Expenses (2020 - 2025)
Evaxion A (EVAX) reported Other Accumulated Expenses of $1.2 million for Q2 2025, up 56.5% on a YoY basis from $738000.0 in Q2 2024, and up 24.6% quarter-over-quarter from $927000.0 in Q4 2024.
Evaxion A (EVAX) Other Accumulated Expenses (2020 - 2025) Analysis & Trends
Evaxion A has reported Other Accumulated Expenses for 6 years, with the latest figure at $1.2 million in Q2 2025.
- For the quarter ending Q2 2025, Other Accumulated Expenses rose 56.5% year-over-year to $1.2 million; the trailing twelve-month figure through Jun 2025 stood at $1.2 million (up 56.5% YoY), and the FY2024 full-year result was $927000.0, down 7.85% from the prior year.
- Other Accumulated Expenses for Q2 2025 stood at $1.2 million, up from $927000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $3.1 million in Q2 2021, with the low at $665000.0 in Q4 2022.
- Historically, Other Accumulated Expenses has averaged $1.4 million across 5 years, with a median of $1.0 million in 2021.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses slumped 70.86% — and 2023, when it surged 60.02%.
- Evaxion A's Other Accumulated Expenses stood at $1.0 million in 2021, then sank by 35.75% to $665000.0 in 2022, then soared by 51.28% to $1.0 million in 2023, then declined by 7.85% to $927000.0 in 2024, then grew by 24.6% to $1.2 million in 2025.
- The last three Other Accumulated Expenses figures came in at $1.2 million (Q2 2025), $927000.0 (Q4 2024), and $738000.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.16 Mn |
| Dec 31, 2024 | 927,000.00 |
| Jun 30, 2024 | 738,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.49 Mn |
| Dec 31, 2022 | 665,000.00 |
| Jun 30, 2022 | 933,000.00 |
| Mar 31, 2022 | 744,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 2.91 Mn |
| Jun 30, 2021 | 3.11 Mn |
| Mar 31, 2021 | 2.55 Mn |
| Dec 31, 2020 | 2.26 Mn |